Literature DB >> 29490976

Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Ke Wang1,2, Bryan Kestenbaum3,2.   

Abstract

The secretion of small molecules by the proximal tubules of the kidneys represents a vital homeostatic function for rapidly clearing endogenous solutes and medications from the circulation. After filtration at the glomerulus, renal blood flow is directed through a network of peritubular capillaries, where transporters of the proximal tubules actively secrete putative uremic toxins and hundreds of commonly prescribed drugs into the urine, including protein-bound substances that cannot readily cross the glomerular basement membrane. Despite its central physiologic importance, tubular secretory clearance is rarely measured or even estimated in clinical or research settings. Major barriers to estimating tubular solute clearance include uncertainty regarding optimal endogenous secretory markers and a lack of standardized laboratory assays. The creation of new methods to measure tubular secretion could catalyze advances in kidney disease research and clinical care. Differences in secretory clearance relative to the GFR could help distinguish among the causes of CKD, particularly for disorders that primarily affect the tubulointerstitium. As the primary mechanism by which the kidneys excrete medications, tubular secretory clearance offers promise for improving kidney medication dosing, which is currently exclusively on the basis of filtration. The differing metabolic profiles of retained solutes eliminated by secretion versus glomerular filtration suggest that secretory clearance could uniquely inform uremic toxicity, refine existing measures of residual kidney function, and improve prediction of cardiovascular and kidney disease outcomes. Interdisciplinary research across clinical, translational, and laboratory medicine is needed to bring this often neglected kidney function into the limelight.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Capillaries; Chronic; Glomerular Basement Membrane; Interdisciplinary Research; Metabolome; Renal Circulation; Renal Insufficiency; Uncertainty; chronic kidney disease; creatinine clearance; drug excretion; glomerular filtration rate; kidney; proximal tubule; renal proximal tubule cell; tubule cells; uremia

Mesh:

Year:  2018        PMID: 29490976      PMCID: PMC6086711          DOI: 10.2215/CJN.12001017

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  52 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.

Authors:  Douglas H Sweet; Lauretta M S Chan; Ramsey Walden; Xiao-Ping Yang; David S Miller; John B Pritchard
Journal:  Am J Physiol Renal Physiol       Date:  2002-12-17

3.  Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

Authors:  Satohiro Masuda; Tomohiro Terada; Atsushi Yonezawa; Yuko Tanihara; Koshiro Kishimoto; Toshiya Katsura; Osamu Ogawa; Ken-ichi Inui
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

4.  Direct demonstration of fluid secretion by glomerular renal tubules in a marine teleost.

Authors:  K W Beyenbach
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

5.  Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males.

Authors:  S E Bäck; B Ljungberg; I Nilsson-Ehle; O Borgå; P Nilsson-Ehle
Journal:  Scand J Clin Lab Invest       Date:  1989-11       Impact factor: 1.713

6.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

7.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

8.  Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats.

Authors:  Ayinuer Adijiang; Sumie Goto; Satsuki Uramoto; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  Nephrol Dial Transplant       Date:  2008-03-11       Impact factor: 5.992

9.  Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.

Authors:  C G Kallenberg; C Schweitzer; P E de Jong; A J Donker; G K van der Hem
Journal:  Clin Nephrol       Date:  1984-11       Impact factor: 0.975

10.  Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

Authors:  Danyelle M Townsend; Mei Deng; Lei Zhang; Maia G Lapus; Marie H Hanigan
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  32 in total

1.  Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model.

Authors:  Munsoor A Hanifa; Martin Skott; Raluca G Maltesen; Bodil S Rasmussen; Søren Nielsen; Jørgen Frøkiær; Troels Ring; Reinhard Wimmer
Journal:  Metabolomics       Date:  2019-08-17       Impact factor: 4.290

Review 2.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

3.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

4.  Impaired Tubular Secretion of Organic Solutes in Acute Kidney Injury.

Authors:  Frank J O'Brien; Robert D Mair; Natalie S Plummer; Timothy W Meyer; Scott M Sutherland; Tammy L Sirich
Journal:  Kidney360       Date:  2020-08-27

Review 5.  Functional Reserve of the Kidney.

Authors:  Armando Armenta; Magdalena Madero; Bernardo Rodriguez-Iturbe
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-10       Impact factor: 8.237

6.  Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.

Authors:  Alexandra K Lee; Ronit Katz; Vasantha Jotwani; Pranav S Garimella; Walter T Ambrosius; Alfred K Cheung; Lisa H Gren; Javier A Neyra; Henry Punzi; Kalani L Raphael; Michael G Shlipak; Joachim H Ix
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

7.  An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.

Authors:  DengFeng Li; James A Snipes; Mariana Murea; Anthony J A Molina; Jasmin Divers; Barry I Freedman; Lijun Ma; Snezana Petrovic
Journal:  Am J Nephrol       Date:  2020-08-31       Impact factor: 3.754

8.  Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.

Authors:  Diana J Schreier; Kianoush B Kashani; Ankit Sakhuja; Kristin C Mara; Mohammad S Tootooni; Heather A Personett; Sarah Nelson; Andrew D Rule; James M Steckelberg; Aaron J Tande; Erin F Barreto
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

Review 9.  The Drosophila Malpighian tubule as a model for mammalian tubule function.

Authors:  Aylin R Rodan
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-09       Impact factor: 2.894

Review 10.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.